About this item:

553 Views | 636 Downloads

Author Notes:

Address correspondence to D.B. Barr, Department of Environmental Health, Rollins School of Public Health, 1518 Clifton Rd. NE, Mailstop: 1518-002-2BB. Emory University, Atlanta, GA 30322 USA. Telephone: (404) 727-9605. E-mail: dbbarr@emory.edu

This manuscript is based upon the work of the Biomonitoring Working Group of the NIEHS Exposome Workshop held 14–15 January 2015 in Research Triangle Park, NC, USA.

Author Disclosures: K.K.D. and D.B.B are supported by Emory University’s Health and Exposome Research Center: Understanding Lifetime Exposures (HERCULES; grant P30 ES019776).

M.A.L. has a patent that he shares with Ciencia, Inc. for a biomonitoring instrument that uses both grating-coupled surface plasmon resonance (GCSPR) imaging and grating-coupled surface plasmon–coupled emission (GCSPCE) imaging in a microarray format for the analysis of functional cell phenotyping.

M.A.L. has consulted for Ciencia, Inc. in the past, but is not currently compensated as a consultant.

M.A.L. also has had (and currently has) NIH/NIEHS support to develop this technology.

G.J.P. is a scientific advisory board member for Cambridge Isotope Laboratories.

All other authors declare they have no actual or potential competing financial interests.

Subjects:

Research Funding:

This work was supported by the National Institutes of Health (NIH), the National Institute of Environmental Health Sciences (NIEHS) and NIH grant P30 ES019776.

Biomonitoring in the Era of the Exposome.

Tools:

Journal Title:

Environmental Health Perspectives

Volume:

Volume 125, Number 4

Publisher:

, Pages 502-510

Type of Work:

Article | Final Publisher PDF

Abstract:

BACKGROUND: The term "exposome" was coined in 2005 to underscore the importance of the environment to human health and to bring research efforts in line with those on the human genome. The ability to characterize environmental exposures through biomonitoring is key to exposome research efforts. OBJECTIVES: Our objectives were to describe why traditional and nontraditional (exposomic) biomonitoring are both critical in studies aiming to capture the exposome and to make recommendations on how to transition exposure research toward exposomic approaches. We describe the biomonitoring needs of exposome research and approaches and recommendations that will help fill the gaps in the current science. DISCUSSION: Traditional and exposomic biomonitoring approaches have key advantages and disadvantages for assessing exposure. Exposomic approaches differ from traditional biomonitoring methods in that they can include all exposures of potential health significance, whether from endogenous or exogenous sources. Issues of sample availability and quality, identification of unknown analytes, capture of nonpersistent chemicals, integration of methods, and statistical assessment of increasingly complex data sets remain challenges that must continue to be addressed. CONCLUSIONS: To understand the complexity of exposures faced throughout the lifespan, both traditional and nontraditional biomonitoring methods should be used. Through hybrid approaches and the integration of emerging techniques, biomonitoring strategies can be maximized in research to define the exposome.

Copyright information:

Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged

Export to EndNote